GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IOL Chemicals And Pharmaceuticals Ltd (NSE:IOLCP) » Definitions » Equity-to-Asset

IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Equity-to-Asset : 0.73 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is IOL Chemicals And Pharmaceuticals Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. IOL Chemicals And Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹16,593 Mil. IOL Chemicals And Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2024 was ₹22,651 Mil. Therefore, IOL Chemicals And Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.73.

The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Equity-to-Asset or its related term are showing as below:

NSE:IOLCP' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.23   Med: 0.66   Max: 0.78
Current: 0.73

During the past 13 years, the highest Equity to Asset Ratio of IOL Chemicals And Pharmaceuticals was 0.78. The lowest was 0.23. And the median was 0.66.

NSE:IOLCP's Equity-to-Asset is ranked better than
70.63% of 1042 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs NSE:IOLCP: 0.73

IOL Chemicals And Pharmaceuticals Equity-to-Asset Historical Data

The historical data trend for IOL Chemicals And Pharmaceuticals's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IOL Chemicals And Pharmaceuticals Equity-to-Asset Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.78 0.71 0.75 0.72

IOL Chemicals And Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 - 0.72 - 0.73

Competitive Comparison of IOL Chemicals And Pharmaceuticals's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IOL Chemicals And Pharmaceuticals's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Equity-to-Asset falls into.



IOL Chemicals And Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

IOL Chemicals And Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=16115.1/22444
=0.72

IOL Chemicals And Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=16592.8/22651
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IOL Chemicals And Pharmaceuticals  (NSE:IOLCP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


IOL Chemicals And Pharmaceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of IOL Chemicals And Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


IOL Chemicals And Pharmaceuticals Business Description

Traded in Other Exchanges
Address
85, Industrial Area, 'A', Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.

IOL Chemicals And Pharmaceuticals Headlines

No Headlines